Acorda Therapeutics
ACOR
$0.58
Share price
-4.00%
Change (1 day)
-65.71%
Change (1 year)
Categories
Market capitalization of Acorda Therapeutics (ACOR)
Market cap: $14.38 Million
As of March 2023 Acorda Therapeutics has a market cap of $14.38 Million. This makes Acorda Therapeutics the world's 7110th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Acorda Therapeutics from 2006 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $14.38 M | -22.91% |
| 2022 | $18.65 M | -30.3% |
| 2021 | $26.77 M | -31.78% |
| 2020 | $39.24 M | -59.67% |
| 2019 | $97.31 M | -86.83% |
| 2018 | $0.73 B | -26.32% |
| 2017 | $1.00 B | 15.66% |
| 2016 | $0.86 B | -52.86% |
| 2015 | $1.83 B | 7.46% |
| 2014 | $1.71 B | 43.35% |
| 2013 | $1.19 B | 20.68% |
| 2012 | $0.98 B | 4.61% |
| 2011 | $0.94 B | -10.51% |
| 2010 | $1.05 B | 10.55% |
| 2009 | $0.95 B | 23.58% |
| 2008 | $0.77 B | 23.27% |
| 2007 | $0.62 B | 67.45% |
| 2006 | $0.37 B |
End of Day market cap according to different sources
On Mar 30th, 2023 the market cap of Acorda Therapeutics was reported to be:
$14.01 Million
$14.38 Million
$14.01 Million
$14.6 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $12.20 B | 84,749.96% | 🇺🇸 USA |
 Repligen
RGEN | $9.51 B | 66,067.88% | 🇺🇸 USA |
 Affimed
AFMD | $0.12 B | 736.64% | 🇩🇪 Germany |
 BioMarin Pharmaceutical BMRN | $18.31 B | 127,188.40% | 🇺🇸 USA |